<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Interaction of SARS-CoV Proteins with Mitochondrial Innate Immunity Components</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Viral Component</th>
    <th>Target</th>
    <th>Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Structural nucleocapsid protein</td>
    <td>
     <italic>Suppression of IRF responses, interference of RIG-1 activation</italic>
    </td>
    <td>(
     <xref rid="bib59" ref-type="bibr">Kopecky-Bromberg et al., 2007</xref>), (
     <xref rid="bib47" ref-type="bibr">Hu et al., 2017</xref>; 
     <xref rid="bib68" ref-type="bibr">Lu et al., 2011</xref>)
    </td>
   </tr>
   <tr>
    <td>Structural membrane protein</td>
    <td>
     <italic>Suppression of RIG-1/MAVS</italic>
    </td>
    <td>(
     <xref rid="bib102" ref-type="bibr">Siu et al., 2009</xref>)
    </td>
   </tr>
   <tr>
    <td>S1 spike protein</td>
    <td>
     <italic>Induces apoptosis</italic>
    </td>
    <td>(
     <xref rid="bib19" ref-type="bibr">Chen et al., 2018</xref>)
    </td>
   </tr>
   <tr>
    <td>Envelop protein</td>
    <td>
     <italic>Activates NLRP3 inflammasome</italic>
    </td>
    <td>(
     <xref rid="bib80" ref-type="bibr">Nieto-Torres et al., 2015</xref>)
    </td>
   </tr>
   <tr>
    <td>Nsp1</td>
    <td>
     <italic>Suppression of IRF responses (downstream signaling)</italic>
    </td>
    <td>(
     <xref rid="bib51" ref-type="bibr">Jauregui et al., 2013</xref>), (
     <xref rid="bib120" ref-type="bibr">Wathelet et al., 2007</xref>)
    </td>
   </tr>
   <tr>
    <td>Nsp2</td>
    <td>
     <italic>Inhibits PHB1 and 2 (blocking mitochondrial biogenesis)</italic>
    </td>
    <td>(
     <xref rid="bib22" ref-type="bibr">Cornillez-Ty et al., 2009</xref>)
    </td>
   </tr>
   <tr>
    <td>Nsp3</td>
    <td>
     <italic>Suppression of IRF responses (inhibits IRF3 phosphorylation)</italic>
    </td>
    <td>(
     <xref rid="bib75" ref-type="bibr">Mielech et al., 2014</xref>)
    </td>
   </tr>
   <tr>
    <td>Nsp15</td>
    <td>
     <italic>Inhibits MAVS-induced apoptosis</italic>
    </td>
    <td>(
     <xref rid="bib64" ref-type="bibr">Lei et al., 2009</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF3a</td>
    <td>
     <italic>p38 MAP kinase → modulates mitochondrial death pathways</italic>
    </td>
    <td>(
     <xref rid="bib82" ref-type="bibr">Padhan et al., 2008</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF3a</td>
    <td>
     <italic>Activates NLRP3 inflammasome</italic>
    </td>
    <td>(
     <xref rid="bib17" ref-type="bibr">Chen et al., 2019</xref>; 
     <xref rid="bib103" ref-type="bibr">Siu et al., 2019</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF3a</td>
    <td>
     <italic>Suppression of IRF responses (downstream signaling)</italic>
    </td>
    <td>(
     <xref rid="bib76" ref-type="bibr">Minakshi et al., 2009</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF3b</td>
    <td>
     <italic>Suppression of IRF responses (inhibiting the phosphorylation and nuclear translocation of IRF3)</italic>
    </td>
    <td>(
     <xref rid="bib59" ref-type="bibr">Kopecky-Bromberg et al., 2007</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF3b</td>
    <td>
     <italic>Inhibits RIG-1/MAVS</italic>
    </td>
    <td>(
     <xref rid="bib33" ref-type="bibr">Freundt et al., 2009</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF6</td>
    <td>
     <italic>Suppression of IRF responses (downstream signaling)</italic>
    </td>
    <td>(
     <xref rid="bib59" ref-type="bibr">Kopecky-Bromberg et al., 2007</xref>), (
     <xref rid="bib35" ref-type="bibr">Frieman et al., 2007</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF7a</td>
    <td>
     <italic>Induces apoptosis</italic>
    </td>
    <td>(
     <xref rid="bib110" ref-type="bibr">Tan et al., 2007</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF8a</td>
    <td>
     <italic>Increased mitochondrial membrane potential, ROS, and apoptosis</italic>
    </td>
    <td>(
     <xref rid="bib16" ref-type="bibr">Chen et al., 2007</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF8b</td>
    <td>
     <italic>Activates NLRP3 inflammasome</italic>
    </td>
    <td>(
     <xref rid="bib98" ref-type="bibr">Shi et al., 2019</xref>)
    </td>
   </tr>
   <tr>
    <td>ORF9b</td>
    <td>
     <italic>Inhibits MAVS, induces degradation of DRP-1</italic>
    </td>
    <td>(
     <xref rid="bib97" ref-type="bibr">Shi et al., 2014</xref>)
    </td>
   </tr>
   <tr>
    <td>SARS-CoV PLpro</td>
    <td>
     <italic>Suppression of IRF responses (inhibits IRF3 phosphorylation)</italic>
    </td>
    <td>(
     <xref rid="bib26" ref-type="bibr">Devaraj et al., 2007</xref>), (
     <xref rid="bib34" ref-type="bibr">Frieman et al., 2009</xref>)
    </td>
   </tr>
   <tr>
    <td>SARS-CoV PLpro</td>
    <td>
     <italic>Disruption of STING</italic>
    </td>
    <td>(
     <xref rid="bib108" ref-type="bibr">Sun et al., 2012</xref>)
    </td>
   </tr>
   <tr>
    <td>SARS-CoV 3C-like protease</td>
    <td>
     <italic>Overexpression changes expression of many mitochondrial proteins</italic>
    </td>
    <td>(
     <xref rid="bib63" ref-type="bibr">Lai et al., 2007</xref>)
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Please see text for available information on SARS-CoV-2 proteins.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
